Our study also revealed that IGF2BP2 is closely associated with remodeling immune microenvironment and that high IGF2BP2 expression is accompanied by a decrease in the number of tumor-infiltrating CD8+ T cells. The gene discussed is IGF2BP2; the disease is neoplasm.